North America Biobanking Market - 2025-2033
North America Biobanking Market reached US$1.09 billion in 2024 and is expected to reach US$2.27 billion by 2033, growing with a CAGR of 8.60% during the forecast period 2026-2033.
The North America Biobanking Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.
A North America Biobanking Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.
By Specimen Type
Both primary and secondary data sources have been used in the global North America Biobanking Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
The North America Biobanking Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.
A North America Biobanking Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.
By Specimen Type
- Blood*
- Tissues
- Cell Lines
- Nucleic Acids
- Others
- Equipments*
- Storage Equipments
- Sample Transport Equipments
- Others
- Consumables
- Tubes
- Vials
- Kits
- Services
- Storage Services
- Processing Services
- Sample Analysis
- Software
- Sample Tracking Software
- Data Management Software
- Manual Storage*
- Automated Storage
- Therapeutic Research*
- Life Science Research
- Regenerative Medicine
- Clinical Diagnostics
- Personalized Medicine
- Others
- Pharmaceutical & Biotechnology Companies*
- Academic & Research Institutes
- Hospitals & Clinics
- Others
- Go-to-market Strategy.
- Neutral perspective on the market performance.
- Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
- Customized regional/country reports as per request and country level analysis.
- Potential & niche segments and regions exhibiting promising growth covered.
- Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).
Both primary and secondary data sources have been used in the global North America Biobanking Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
1. MARKET INTRODUCTION AND SCOPE
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS
2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet by Specimen Type
2.4. Snippet by Product & Services
2.5. Snippet by Storage Type
2.6. Snippet by Application
2.7. Snippet by End-User
2.8. Snippet by Region
3. DYNAMICS
3.1. Impacting Factors
3.1.1. Drivers
3.1.1.1. Rapid Advancements in Biotechnology & Genomic Research
3.1.2. Restraints
3.1.2.1. Ethical & Legal Challenges in Sample Collection and Usage
3.1.3. Opportunity
3.1.4. Impact Analysis
4. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK
4.1. Market Leaders and Pioneers in North America
4.1.1. Emerging Pioneers and Prominent Players
4.1.2. Established leaders with largest selling Brand
4.1.3. Market leaders with established Product
4.2. CXO Perspectives
4.3. Latest Developments and Breakthroughs
4.4. Case Studies/Ongoing Research on Biobanking
4.5. Regulatory and Reimbursement Landscape
4.6. Porter’s Five Force Analysis
4.7. Supply Chain Analysis
4.8. Patent Analysis
4.9. SWOT Analysis
4.10. Unmet Needs and Gaps
4.11. Recommended Strategies for Market Entry and Expansion
4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
4.13. Pricing Analysis and Price Dynamics
4.14. Key Opinion Leaders
5. BIOBANKING MARKET, BY SPECIMEN TYPE
5.1. Introduction
5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Specimen Type
5.1.2. Market Attractiveness Index, By Specimen Type
5.2. Blood*
5.2.1. Introduction
5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
5.3. Tissues
5.4. Cell Lines
5.5. Nucleic Acids
5.6. Others
6. BIOBANKING MARKET, BY PRODUCT & SERVICES
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product & Services
6.1.2. Market Attractiveness Index, By Product & Services
6.2. Equipments*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.2.3. Storage Equipments
6.2.4. Sample Transport Equipments
6.2.5. Others
6.3. Consumables
6.3.1. Tubes
6.3.2. Vials
6.3.3. Kits
6.3.4. Others
6.4. Services
6.4.1. Storage Services
6.4.2. Processing Services
6.4.3. Sample Analysis
6.4.4. Others
6.5. Software
6.5.1. Sample Tracking Software
6.5.2. Data Management Software
7. BIOBANKING MARKET, BY STORAGE TYPE
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Storage Type
7.1.2. Market Attractiveness Index, By Storage Type
7.2. Manual Storage*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Automated Storage
8. BIOBANKING MARKET, BY APPLICATION
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Therapeutic Research*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Life Science Research
8.4. Regenerative Medicine
8.5. Clinical Diagnostics
8.6. Personalized Medicine
8.7. Others
9. BIOBANKING MARKET, BY END-USER
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.1.2. Market Attractiveness Index, By End-User
9.2. Pharmaceutical & Biotechnology Companies*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Academic & Research Institutes
9.4. Hospitals & Clinics
9.5. Others
10. COMPETITIVE LANDSCAPE AND MARKET POSITIONING
10.1. Competitive Overview and Key Market Players
10.2. Market Share Analysis and Positioning Matrix
10.3. Strategic Partnerships, Mergers & Acquisitions
10.4. Key Developments in Product Portfolios and Innovations
10.5. Company Benchmarking
11. COMPANY PROFILES
11.1. Thermo Fisher Scientific Inc.*
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Financial Overview
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.2. QIAGEN N.V.
11.3. PHC Corporation
11.4. Merck KGaA
11.5. Avantor, Inc.
11.6. Cryoport Systems, LLC.
11.7. Tecan Group Ltd.
11.8. Azenta US Inc.
11.9. Greiner Bio-One North America Inc.
11.10. Hamilton Company (LIST NOT EXHAUSTIVE)
12. ASSUMPTION AND RESEARCH METHODOLOGY
12.1. Data Collection Methods
12.2. Data Triangulation
12.3. Forecasting Techniques
12.4. Data Verification and Validation
13. APPENDIX
13.1. About Us and Services
13.2. Contact Us
Suggestions for Related Report
• Global Biobanking Services Market (https://www.datamintelligence.com/research-report/biobanking-services-market)
• Global Regenerative Medicine Market (https://www.datamintelligence.com/research-report/regenerative-medicine-market)
For more biotechnology related reports, please click here (https://www.datamintelligence.com/industry-verticals/biotechnology)
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS
2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet by Specimen Type
2.4. Snippet by Product & Services
2.5. Snippet by Storage Type
2.6. Snippet by Application
2.7. Snippet by End-User
2.8. Snippet by Region
3. DYNAMICS
3.1. Impacting Factors
3.1.1. Drivers
3.1.1.1. Rapid Advancements in Biotechnology & Genomic Research
3.1.2. Restraints
3.1.2.1. Ethical & Legal Challenges in Sample Collection and Usage
3.1.3. Opportunity
3.1.4. Impact Analysis
4. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK
4.1. Market Leaders and Pioneers in North America
4.1.1. Emerging Pioneers and Prominent Players
4.1.2. Established leaders with largest selling Brand
4.1.3. Market leaders with established Product
4.2. CXO Perspectives
4.3. Latest Developments and Breakthroughs
4.4. Case Studies/Ongoing Research on Biobanking
4.5. Regulatory and Reimbursement Landscape
4.6. Porter’s Five Force Analysis
4.7. Supply Chain Analysis
4.8. Patent Analysis
4.9. SWOT Analysis
4.10. Unmet Needs and Gaps
4.11. Recommended Strategies for Market Entry and Expansion
4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
4.13. Pricing Analysis and Price Dynamics
4.14. Key Opinion Leaders
5. BIOBANKING MARKET, BY SPECIMEN TYPE
5.1. Introduction
5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Specimen Type
5.1.2. Market Attractiveness Index, By Specimen Type
5.2. Blood*
5.2.1. Introduction
5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
5.3. Tissues
5.4. Cell Lines
5.5. Nucleic Acids
5.6. Others
6. BIOBANKING MARKET, BY PRODUCT & SERVICES
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product & Services
6.1.2. Market Attractiveness Index, By Product & Services
6.2. Equipments*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.2.3. Storage Equipments
6.2.4. Sample Transport Equipments
6.2.5. Others
6.3. Consumables
6.3.1. Tubes
6.3.2. Vials
6.3.3. Kits
6.3.4. Others
6.4. Services
6.4.1. Storage Services
6.4.2. Processing Services
6.4.3. Sample Analysis
6.4.4. Others
6.5. Software
6.5.1. Sample Tracking Software
6.5.2. Data Management Software
7. BIOBANKING MARKET, BY STORAGE TYPE
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Storage Type
7.1.2. Market Attractiveness Index, By Storage Type
7.2. Manual Storage*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Automated Storage
8. BIOBANKING MARKET, BY APPLICATION
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Therapeutic Research*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Life Science Research
8.4. Regenerative Medicine
8.5. Clinical Diagnostics
8.6. Personalized Medicine
8.7. Others
9. BIOBANKING MARKET, BY END-USER
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.1.2. Market Attractiveness Index, By End-User
9.2. Pharmaceutical & Biotechnology Companies*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Academic & Research Institutes
9.4. Hospitals & Clinics
9.5. Others
10. COMPETITIVE LANDSCAPE AND MARKET POSITIONING
10.1. Competitive Overview and Key Market Players
10.2. Market Share Analysis and Positioning Matrix
10.3. Strategic Partnerships, Mergers & Acquisitions
10.4. Key Developments in Product Portfolios and Innovations
10.5. Company Benchmarking
11. COMPANY PROFILES
11.1. Thermo Fisher Scientific Inc.*
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Financial Overview
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.2. QIAGEN N.V.
11.3. PHC Corporation
11.4. Merck KGaA
11.5. Avantor, Inc.
11.6. Cryoport Systems, LLC.
11.7. Tecan Group Ltd.
11.8. Azenta US Inc.
11.9. Greiner Bio-One North America Inc.
11.10. Hamilton Company (LIST NOT EXHAUSTIVE)
12. ASSUMPTION AND RESEARCH METHODOLOGY
12.1. Data Collection Methods
12.2. Data Triangulation
12.3. Forecasting Techniques
12.4. Data Verification and Validation
13. APPENDIX
13.1. About Us and Services
13.2. Contact Us
Suggestions for Related Report
• Global Biobanking Services Market (https://www.datamintelligence.com/research-report/biobanking-services-market)
• Global Regenerative Medicine Market (https://www.datamintelligence.com/research-report/regenerative-medicine-market)
For more biotechnology related reports, please click here (https://www.datamintelligence.com/industry-verticals/biotechnology)
